Tildrakizumab
Tildrakizumab
Common
Rarity: Common
The most frequent rarity: most Wikipedia articles become Commons.
Rarity follows how well known the article is: its views on the French and English Wikipedia over a year, and the number of languages it exists in.
At a glance
- Class
- Notion
- Domain
- Science and technology
- In collections
- Nobody has pulled it yet.
What Wikipedia says
Tildrakizumab, sold under the brand name Ilumya among others, is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. It is approved for the treatment of adults with moderate-to-severe plaque psoriasis in the United States and in the European Union.
Excerpt from the Wikipedia article “Tildrakizumab”, under the CC BY-SA 4.0 license. Read the article on Wikipedia
Open free boosters and add Tildrakizumab to your collection.
Play for free




